Subscribe To
KA / Kineta to Present at Jefferies Healthcare Conference
KA News
By GlobeNewsWire
October 9, 2023
Kineta to Present Preclinical Data on VISTA Blocking KVA12123 at Immuno US 2023
SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun more_horizontal
By GlobeNewsWire
September 28, 2023
Kineta Announces Participation at October Investor Conferences
SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal
By GlobeNewsWire
September 25, 2023
Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy
SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal
By GlobeNewsWire
May 23, 2023
Kineta to Present at Jefferies Healthcare Conference
SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immuno more_horizontal
By GlobeNewsWire
April 3, 2023
Kineta to Present at 22nd Annual Needham Healthcare Conference
SEATTLE, April 03, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal
By GlobeNewsWire
March 22, 2023
Kineta to Present VISTA Biomarker Data at AACR Annual Meeting 2023
SEATTLE, March 22, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu more_horizontal